Free Trial

Globus Medical (GMED) Short Interest Ratio & Short Volume

Globus Medical logo
$76.65 +0.59 (+0.78%)
Closing price 03/25/2025 03:58 PM Eastern
Extended Trading
$75.98 -0.67 (-0.87%)
As of 03/25/2025 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Globus Medical Short Interest Data

Globus Medical (GMED) has a short interest of 2.62 million shares, representing 2.36% of the float (the number of shares available for trading by the public). This marks a 12.93% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.3, indicating that it would take 2.3 days of the average trading volume of 998,645 shares to cover all short positions.

Current Short Interest
2,620,000 shares
Previous Short Interest
2,320,000 shares
Change Vs. Previous Month
+12.93%
Dollar Volume Sold Short
$210.49 million
Short Interest Ratio
2.3 Days to Cover
Last Record Date
February 28, 2025
Outstanding Shares
137,542,000 shares
Short Percent of Float
2.36%
Today's Trading Volume
1,511,866 shares
Average Trading Volume
998,645 shares
Today's Volume Vs. Average
151%
Short Selling Globus Medical?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Globus Medical and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GMED Short Interest Over Time

GMED Days to Cover Over Time

GMED Percentage of Float Shorted Over Time

Remove Ads

Globus Medical Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/28/20252,620,000 shares $210.49 million +12.9%2.4%2.3 $80.34
2/15/20252,320,000 shares $194.86 million +6.4%2.1%2.1 $83.99
1/31/20252,180,000 shares $202.09 million -12.8%N/A1.9 $92.70
1/15/20252,500,000 shares $226.40 million +0.4%N/A2.4 $90.56
12/31/20242,490,000 shares $205.95 million +4.6%N/A2.6 $82.71
12/15/20242,380,000 shares $196.16 million -2.5%N/A2.7 $82.42
11/30/20242,440,000 shares $208.89 million -12.5%N/A3 $85.61
11/15/20242,790,000 shares $226.27 million -2.5%N/A3.5 $81.10
10/31/20242,860,000 shares $210.32 million +0.7%N/A3.5 $73.54
10/15/20242,840,000 shares $210.30 million -16.7%N/A3.5 $74.05
9/30/20243,410,000 shares $243.95 million -3.4%N/A4.3 $71.54
9/15/20243,530,000 shares $246.22 million -19.6%N/A4.1 $69.75
8/31/20244,390,000 shares $319.15 million No ChangeN/A4.8 $72.70
8/15/20244,390,000 shares $301.99 million -9.1%N/A4.6 $68.79
7/31/20244,830,000 shares $347.86 million -29.0%N/A4.6 $72.02
7/15/20246,800,000 shares $489.87 million -5.0%N/A6.7 $72.04
6/30/20247,160,000 shares $490.39 million +4.4%N/A7 $68.49
6/15/20246,860,000 shares $450.08 million -2.6%N/A6.6 $65.61
5/31/20247,040,000 shares $472.45 million -2.0%N/A6.5 $67.11
5/15/20247,180,000 shares $463.61 million -20.1%N/A6.5 $64.57
4/30/20248,990,000 shares $447.61 million +19.7%N/A8 $49.79
4/15/20247,510,000 shares $389.09 million -3.2%N/A7.2 $51.81
3/31/20247,760,000 shares $416.25 million +32.4%N/A6.7 $53.64
3/15/20245,860,000 shares $301.26 million +2.3%N/A5.1 $51.41
2/29/20245,730,000 shares $309.36 million -0.9%N/A4.8 $53.99
2/15/20245,780,000 shares $309.40 million +8.7%N/A4.7 $53.53
1/31/20245,320,000 shares $280.66 million +55.1%N/A4.3 $52.76
1/15/20243,430,000 shares $192.83 million No ChangeN/A2.6 $56.22
12/31/20233,430,000 shares $182.78 million +0.9%N/A2.7 $53.29
12/15/20233,400,000 shares $168.44 million +6.3%N/A2.6 $49.54
11/30/20233,200,000 shares $143.74 million -13.0%N/A2.3 $44.92
11/15/20233,680,000 shares $168.58 million -7.8%N/A1.8 $45.81
10/31/20233,990,000 shares $182.38 million -6.3%N/A2 $45.71
10/15/20234,260,000 shares $226.29 million -4.1%N/A2.3 $53.12
9/30/20234,440,000 shares $220.45 million +3.0%N/A2.5 $49.65
9/15/20234,310,000 shares $215.59 million -59.2%N/A2.6 $50.02
8/31/202310,570,000 shares $572.31 million +32.6%N/A6.8 $54.15
8/15/20237,970,000 shares $455.09 million -1.5%10.3%9.3 $57.10
7/31/20238,090,000 shares $487.42 million -1.6%10.5%8.7 $60.25
7/15/20238,220,000 shares $509.23 million +3.9%10.6%7.6 $61.95
Trump’s Final Plan (Ad)

Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’s secret plan to trigger the greatest transfer of wealth since FDR and LBJ – trillions of dollars could be redistributed.

6/30/20237,910,000 shares $470.96 million +2.3%10.2%7 $59.54
6/15/20237,730,000 shares $453.98 million -3.9%10.0%6.2 $58.73
5/31/20238,040,000 shares $435.21 million +4.4%10.4%5.9 $54.13
5/15/20237,700,000 shares $436.28 million +24.0%10.0%5.3 $56.66
4/30/20236,210,000 shares $361.05 million +7.4%8.0%3.5 $58.14
4/15/20235,780,000 shares $332.58 million +13.1%7.5%3.7 $57.54
3/31/20235,110,000 shares $289.43 million +12.8%6.6%3.4 $56.64
3/15/20234,530,000 shares $237.87 million +17.1%5.9%3.4 $52.51
2/28/20233,870,000 shares $225.78 million +50.0%5.0%3.4 $58.34
2/15/20232,580,000 shares $158.57 million -47.4%3.3%2.5 $61.46
1/31/20234,900,000 shares $369.95 million +1.0%6.4%6.4 $75.50
1/15/20234,850,000 shares $360.84 million +2.1%6.3%8.5 $74.40
12/30/20224,750,000 shares $352.78 million -5.6%6.2%8.1 $74.27
12/15/20225,030,000 shares $363.92 million -15.2%6.6%8.6 $72.35
11/30/20225,930,000 shares $438.17 million +2.4%7.7%9.5 $73.89
11/15/20225,790,000 shares $415.61 million +7.6%7.5%9.4 $71.78
10/31/20225,380,000 shares $360.46 million +9.4%N/A9.4 $67.00
10/15/20224,920,000 shares $298.99 million +0.6%N/A8.4 $60.77
9/30/20224,890,000 shares $291.30 million +1.0%N/A8.3 $59.57
9/15/20224,840,000 shares $297.71 million -7.5%N/A8 $61.51
8/31/20225,230,000 shares $309.56 million +0.8%N/A8.3 $59.19
8/15/20225,190,000 shares $350.53 million +3.0%N/A8.3 $67.54
7/31/20225,040,000 shares $295.80 million +1.4%6.7%7.1 $58.69
7/15/20224,970,000 shares $280.01 million +5.1%6.6%6.1 $56.34
6/30/20224,730,000 shares $265.54 million +2.2%6.3%5.4 $56.14
6/15/20224,630,000 shares $257.34 million +2.7%6.2%5.3 $55.58
5/31/20224,510,000 shares $300.37 million +2.5%N/A5.4 $66.60
5/15/20224,400,000 shares $279.80 million +30.6%N/A5.2 $63.59
4/30/20223,370,000 shares $223.16 million -13.8%N/A4.3 $66.22
4/15/20223,910,000 shares $303.03 million +51.0%N/A5.5 $77.50
3/31/20222,590,000 shares $191.09 million +14.6%N/A4.4 $73.78
3/15/20222,260,000 shares $148.91 million +137.5%N/A4.2 $65.89
2/28/2022951,500 shares $66.91 million -25.7%N/A1.7 $70.32
2/15/20221,280,000 shares $88.64 million +34.1%N/A2.4 $69.25
1/31/2022954,600 shares $63.70 million +27.8%N/A1.8 $66.73
1/15/2022747,000 shares $54.87 million -19.8%N/A1.5 $73.45
12/31/2021931,300 shares $67.24 million -9.6%N/A1.9 $72.20
12/15/20211,030,000 shares $68.95 million +27.4%N/A2.1 $66.94
11/30/2021808,400 shares $50.62 million +3.4%N/A1.8 $62.62
11/15/2021782,200 shares $55.37 million -31.4%N/A1.7 $70.79
10/29/20211,140,000 shares $87.97 million -14.9%N/A2.7 $77.17
10/15/20211,340,000 shares $102.42 million +14.5%1.7%3.2 $76.43
9/30/20211,170,000 shares $89.65 million +1.7%1.5%2.7 $76.62
9/15/20211,150,000 shares $93.29 million +0.9%1.5%2.5 $81.12
8/31/20211,140,000 shares $93.02 million -1.7%1.5%2.7 $81.60
8/13/20211,160,000 shares $88.64 million -17.1%1.5%2.9 $76.41
7/30/20211,400,000 shares $116.44 million -3.5%1.8%3.3 $83.17
7/15/20211,450,000 shares $114.62 million +0.7%1.9%3.3 $79.05
6/30/20211,440,000 shares $111.64 million +5.1%1.9%3.3 $77.53
6/15/20211,370,000 shares $99.94 million +13.2%1.8%3.3 $72.95
Trump’s Final Plan (Ad)

Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’s secret plan to trigger the greatest transfer of wealth since FDR and LBJ – trillions of dollars could be redistributed.

5/28/20211,210,000 shares $87.19 million -2.4%1.6%2.7 $72.06
5/14/20211,240,000 shares $88.45 million -37.1%N/A2.6 $71.33
4/30/20211,970,000 shares $142.84 million +28.8%N/A4 $72.51
4/15/20211,530,000 shares $105.46 million +19.5%2.0%3.3 $68.93
3/31/20211,280,000 shares $78.18 million +6.7%1.7%2.8 $61.08
3/15/20211,200,000 shares $74.93 million -4.8%N/A2.4 $62.44
2/26/20211,260,000 shares $78.09 million -15.4%N/A2.4 $61.98
2/12/20211,490,000 shares $99.73 million +7.2%N/A2.7 $66.93
1/29/20211,390,000 shares $87.58 million +6.1%1.8%2.6 $63.01
1/15/20211,310,000 shares $85.22 million -9.0%1.7%2.3 $65.05
12/31/20201,440,000 shares $93.48 million +2.9%1.9%2.4 $64.92
12/15/20201,400,000 shares $86.79 million -27.8%1.9%2.3 $61.99
11/30/20201,940,000 shares $116.24 million -2.5%2.6%3.3 $59.92
11/15/20201,990,000 shares $112.79 million -8.7%2.6%3.4 $56.68
10/30/20202,180,000 shares $114.38 million +6.3%2.9%3.7 $52.47
10/15/20202,050,000 shares $112.32 million +16.5%2.8%3.4 $54.79
9/30/20201,760,000 shares $87.16 million +29.4%2.4%2.8 $49.52
9/15/20201,360,000 shares $74.08 million -30.3%1.8%1.6 $54.47
8/31/20201,950,000 shares $110.21 million -15.2%2.6%2 $56.52
8/14/20202,300,000 shares $126.16 million -45.5%3.1%2.1 $54.85
7/31/20204,220,000 shares $203.32 million -6.4%5.7%3.3 $48.18
7/15/20204,510,000 shares $207.51 million +4.2%6.1%3.6 $46.01
6/30/20204,330,000 shares $205.24 million -20.7%5.9%3.4 $47.40
6/15/20205,460,000 shares $261.97 million -2.5%7.4%4.7 $47.98
5/29/20205,600,000 shares $306.04 million +12.5%7.6%4.6 $54.65
5/15/20204,980,000 shares $228.18 million +8.0%6.7%4.1 $45.82
4/30/20204,610,000 shares $218.79 million +7.7%6.2%4.6 $47.46
4/15/20204,280,000 shares $191.06 million +12.9%5.6%4.6 $44.64
3/31/20203,790,000 shares $177.22 million +31.3%5.0%4.1 $46.76

GMED Short Interest - Frequently Asked Questions

What is Globus Medical's current short interest?

Short interest is the volume of Globus Medical shares that have been sold short but have not yet been closed out or covered. As of February 28th, investors have sold 2,620,000 shares of GMED short. 2.36% of Globus Medical's shares are currently sold short. Learn More on Globus Medical's current short interest.

What is a good short interest ratio for Globus Medical?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GMED shares currently have a short interest ratio of 2.0. Learn More on Globus Medical's short interest ratio.

Which institutional investors are shorting Globus Medical?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Globus Medical: Citadel Advisors LLC, Jane Street Group LLC, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., and PEAK6 LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Globus Medical?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.36% of Globus Medical's floating shares are currently sold short.

Is Globus Medical's short interest increasing or decreasing?

Globus Medical saw a increase in short interest in February. As of February 28th, there was short interest totaling 2,620,000 shares, an increase of 12.9% from the previous total of 2,320,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Globus Medical's short interest compare to its competitors?

2.36% of Globus Medical's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Globus Medical: IDEXX Laboratories, Inc. (3.40%), ResMed Inc. (5.99%), DexCom, Inc. (2.53%), STERIS plc (1.06%), Insulet Co. (4.11%), Baxter International Inc. (4.12%), Hologic, Inc. (2.00%), Masimo Co. (6.79%), Teleflex Incorporated (2.42%), Integer Holdings Co. (6.85%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks.

What does it mean to sell short Globus Medical stock?

Short selling GMED is an investing strategy that aims to generate trading profit from Globus Medical as its price is falling. GMED shares are trading up $0.59 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Globus Medical?

A short squeeze for Globus Medical occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GMED, which in turn drives the price of the stock up even further.

How often is Globus Medical's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GMED, twice per month. The most recent reporting period available is February, 28 2025.




This page (NYSE:GMED) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners